Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
223.7 USD | -1.76% | -5.00% | -13.60% |
03:58pm | Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating | MT |
03:33pm | Biogen: agreement to acquire HI-Bio | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.60% | 33.15B | |
-2.99% | 89.49B | |
+2.50% | 40.67B | |
+62.67% | 26.45B | |
-20.05% | 14.69B | |
-8.06% | 12.89B | |
-12.64% | 11.54B | |
-43.92% | 11.34B | |
+3.90% | 8.84B | |
-11.11% | 7.96B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 11